Candel Therapeutics, Inc. (CADL) Reports Q2 Loss of $0.74/sh

Go back to Candel Therapeutics, Inc. (CADL) Reports Q2 Loss of $0.74/sh
(NASDAQ: CADL) Delayed: 9.08 -0.07 (0.77%)
Previous Close $9.15    52 Week High
Open $8.96    52 Week Low
Day High $9.32    P/E N/A 
Day Low $8.96    EPS
Volume 992,654